¬â¬Ñ¬Ò¬à¬ä¬Ñ ¬Ó ¬â¬à¬ã¬ã¬Ú¬Ú ¬à¬Ò¬å¬é¬Ö¬ß¬Ú¬Ö ¬ß¬Ñ¬è¬á¬â¬à¬Ö¬Ü¬ä | ||||||||||
SdvillEvato | 2022-09-08 | 143 | ||||||||
¬Ý¬Ñ¬ß¬Õ¬ê¬Ñ¬æ¬ä¬ß¬í¬Û ¬Õ¬Ú¬Ù¬Ñ¬Û¬ß ¬à¬Ò¬å¬é¬Ö¬ß¬Ú¬Ö ¬ã ¬ß¬å¬Ý¬ñ ¬ã¬Ñ¬Þ¬à¬ã¬ä¬à¬ñ¬ä¬Ö¬Ý¬î¬ß¬à Tegs: ¬å¬á¬â¬Ñ¬Ó¬Ý¬Ö¬ß¬Ú¬Ö ¬á¬â¬à¬Ö¬Ü¬ä¬Ñ¬Þ¬Ú ¬æ¬å¬ß¬Õ¬Ñ¬Þ¬Ö¬ß¬ä¬Ñ¬Ý¬î¬ß¬í¬Û ¬Ü¬å¬â¬ã https://tgu-dpo.ru/ ¬á¬ã¬Ú¬ç¬à¬Ý¬à¬Ô ¬Ü¬à¬ß¬ã¬å¬Ý¬î¬ä¬Ñ¬ß¬ä ¬Ü¬å¬â¬ã¬í ¬æ¬Ú¬ä¬ß¬Ö¬ã ¬ä¬â¬Ö¬ß¬Ö¬â ¬à¬Ò¬å¬é¬Ö¬ß¬Ú¬Ö ¬Ù¬Ñ¬à¬é¬ß¬à ¬Þ¬Ö¬ä¬à¬Õ¬Ú¬ã¬ä ¬à¬Ò¬â¬Ñ¬Ù¬à¬Ó¬Ñ¬ä¬Ö¬Ý¬î¬ß¬í¬ç ¬á¬â¬à¬Ô¬â¬Ñ¬Þ¬Þ ¬à¬Ò¬å¬é¬Ö¬ß¬Ú¬Ö ¬Ò¬Ö¬ã¬á¬Ý¬Ñ¬ä¬ß¬à |
18586 | endostatin murine, recombinant ¬Ü¬å¬á¬Ú¬ä¬î ¬à¬ß¬Ý¬Ñ... | LavillEvat | 2024-04-03 | 3 | |
18585 | anti-histone deacetylase 1 (hdac1) anti& ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2024-03-31 | 4 | |
18584 | First revalidation, dilatation ptosis accountability... | axojaqeera | 2024-01-05 | 31 | |
18583 | L, documentation rotational, expressed accountabilit... | axojaqeera | 2024-01-05 | 31 | |
18582 | ¬Ü¬à¬Ý¬à¬ß¬Ü¬Ñ ¬Õ¬Ý¬ñ ¬Ó¬ï¬Ø¬ç caprisil c18 5 ¬Þ¬Ü¬Þ... | LavillEvat | 2023-10-28 | 65 | |
18581 | pyrex(r) vista(tm) volumetric pipette, & ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2023-10-18 | 59 | |
18580 | 5-chloro-2-[(4-fluorobenzyl)oxy]benzoyl chloride †... | LavillEvat | 2023-10-13 | 65 | |
18579 | human gabrr1 gene orf cdna clone expression plasmid ... | LavillEvat | 2023-10-07 | 69 | |
18578 | Consider rehabilitating total symptom memory, append... | eshuhia | 2023-09-22 | 75 | |
18577 | Consider case-control crescent higher, health-relate... | eshuhia | 2023-09-22 | 69 | |
1 2 3 4 5 6 7 8 9 10 |